Waters Corporation (Milford, Massachusetts) and Bruker BioSciences Corporation (Billerica, Massachusetts) recently entered into a collaboration agreement to provide greater integration and connectivity between Waters? ACQUITY Ultra Performance LC (UPLC) system and Bruker?s mass spectrometry (MS) and nuclear magnetic resonance (NMR) products.
Waters Corporation (Milford, Massachusetts) and Bruker BioSciences Corporation (Billerica, Massachusetts) recently entered into a collaboration agreement to provide greater integration and connectivity between Waters' ACQUITY Ultra Performance LC (UPLC) system and Bruker's mass spectrometry (MS) and nuclear magnetic resonance (NMR) products.
The collaboration will allow direct support of Waters ACQUITY UPLC system in Bruker's HyStar software thus unifying control and results management to combine these technologies. The products of both companies have many applications in the discovery, development, and manufacture of pharmaceuticals, processed foods, beverages, personal care products, and in environmental and food safety laboratories.
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.